UPS Healthcare Accelerates Cold Chain Capabilities
May 24 2021 - 9:00AM
- UPS Cold Chain Solutions brings full suite of end-to-end cold
chain capabilities to customers worldwide
UPS (NYSE: UPS) is expanding its specialty
pharmaceutical offerings by establishing UPS Cold Chain Solutions,
a comprehensive suite of cold chain technologies, best-in-class
capabilities, and new and expanded global facilities providing
complete, end-to-end temperature-controlled logistics.
“Our customers have been taking advantage of our cold chain
capabilities for years, but the pandemic caused UPS to move even
faster to enhance an integrated set of cold chain solutions to
support the future of the pharmaceutical and medical device
industry,” said Wes Wheeler, UPS Healthcare president. “UPS’s
near-perfect, on-time delivery of the COVID-19 vaccine proves how
effectively and efficiently our network handles biologically
derived drugs, even at extreme temperatures.”
Chronic and life-threatening diseases, including cancers,
respiratory, autoimmune and cardiovascular conditions, are the
fastest growing disease categories in the world, creating a rapid
acceleration in the development of biologically derived,
temperature-controlled drugs and therapies. According to the
Biopharma Cold Chain Sourcebook, cold chain trends show 48 percent
growth between 2018 and 2024 for drugs that require at least 2 to 8
degrees Celsius storage and shipping. Additionally, the overall
market for cold chain services (packaging, transportation and data
services) is expected to significantly accelerate growth over the
next three years, growing by 24 percent by 2024, after posting a 10
percent increase from 2019 to 2020.
“The future of the healthcare and specialty pharmaceutical
industries will increasingly rely on robust cold chain networks to
safely deliver temperature-controlled drugs and therapies to
customers,” said Kate Gutmann, UPS chief sales and solutions
officer and SVP, UPS Global Healthcare. “The continued evolution of
our cold chain offerings ensures UPS is ready for the future and
can continue to provide long-term value for our healthcare
customers.”
Managing temperature excursion end-to-endUPS
Cold Chain Solutions is purpose-built to provide pharmaceutical
companies, healthcare providers and laboratories a full, end-to-end
cold chain service offering, including storage and distribution,
transportation, visibility, and quality assurance capabilities to
meet their complex demands for critical products around the
world.
As part of a continued, aggressive strategy to build
sophisticated capabilities in cold chain logistics, UPS Healthcare
is expanding and augmenting its temperature-controlled products and
services, including:
- Cold chain GMP storage capacities – roughly 390,000 square feet
of coolers and freezers installed at UPS facilities to support the
storage of biologics ranging from 2 degrees Celsius to as low as
minus-80 degrees Celsius
- Packaging customization – recommendations for specific
temperature-controlled packaging options to minimize total cost
while ensuring safe and efficient transportation of products
- UPS European cold chain ground network expansion – adding more
ground transportation fleets, better connection between gateways
and teams of experts to create customizable solutions that fit our
customers’ needs
- Transportation efficiencies – four flexible,
temperature-regulated service options via air or ocean freight that
can be configured to meet the needs of the pharmaceutical packaging
and help keep customer costs down
- Precise monitoring with UPS® Premier technology – protocols to
provide pinpoint visibility into covered pallets, boxes, trailers
and packages within 10 feet of their location anywhere in the UPS
network
- Facility updates – construction of two new GDP-compliant,
healthcare-licensed distribution facilities in Italy and Australia,
as well expansions and cold chain retrofit projects to facilities
in The Netherlands, Czechia, Poland, Hungary and the U.S.
“UPS sets a high bar for excellence in cold chain delivery and
logistics, and these current and future investments in innovative
solutions will ensure we keep pushing the bar higher,” Wheeler
said. “For our customers, we will remain focused on delivering on
our commitment to ‘Quality Focused. Patient
Driven.’”
You can learn more about UPS Cold Chain Solutions and other UPS
Healthcare initiatives by visiting: www.ups.com/healthcare.
About UPS Healthcare
UPS Healthcare has 11 million square feet of GMP- and
GDP-compliant healthcare distribution space in 128 facilities in 32
countries. UPS Healthcare services include: inventory management,
temperature-controlled packaging and shipping, storage and
fulfillment of medical devices, labs and clinical trial logistics.
UPS Healthcare’s global infrastructure, its newest UPS Premier
visibility service, its track and trace technology, and its global
quality system are well-suited to meet today’s complex logistics
demands for the pharmaceutical, medical device and laboratory
diagnostic industries.
Contact: UPS Media Relations
pr@ups.com
United Parcel Service (NYSE:UPS)
Historical Stock Chart
From Mar 2024 to Apr 2024
United Parcel Service (NYSE:UPS)
Historical Stock Chart
From Apr 2023 to Apr 2024